Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

282 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2947 (91%)

3240

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT AMLODIPINE 5MG TABLET Resolved 2022-12-15 2023-02-16 178518
ACT AMLODIPINE 10MG TABLET Resolved 2021-09-30 2021-10-07 146443
ACT AMLODIPINE 2.5MG TABLET Resolved 2017-03-17 2017-09-19 3348
ACT AMLODIPINE 5MG TABLET Resolved 2023-02-09 2023-04-28 184204
ACT AMLODIPINE 5MG TABLET Resolved 2020-11-06 2021-01-07 127998
ACT AMLODIPINE 10MG TABLET Resolved 2020-11-06 2021-01-21 128034
ACT AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068
ACT AMPHETAMINE XR 1.25MG 1.25MG 1.25MG 1.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61336
ACT AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
ACT AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-05-06 131679
ACT AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-15 2021-09-09 142610
ACT AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2021-09-23 2021-10-14 146092
ACT AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Avoided shortage 2021-05-20 2021-07-08 139722
ACT AMPHETAMINE XR 5MG 5MG 5MG 5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60075
ACT AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2021-03-25 2021-05-20 136286
ACT AMPHETAMINE XR 6.25MG 6.25MG 6.25MG 6.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61330
ACT AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-03-11 131676
ACT AMPHETAMINE XR 7.5MG 7.5MG 7.5MG 7.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61333
ACT ANASTROZOLE 1MG TABLET Resolved 2020-01-24 2021-01-28 104374
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-09-25 2020-10-22 125031

Showing 1 to 20 of 3240

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-PREGABALIN 25MG CAPSULE Discontinued 2025-05-28 2025-05-28 258631
TEVA-PREGABALIN 150MG CAPSULE Discontinued 2025-05-28 2025-05-28 258627
TEVA-PREGABALIN 225MG CAPSULE Discontinued 2025-05-28 2025-05-28 258622
TEVA-PREGABALIN 75MG CAPSULE Discontinued 2020-07-10 2020-07-10 120033
TEVA-PREGABALIN 300MG CAPSULE Discontinued 2025-05-28 2025-05-28 258756
TEVA-PROCTOSONE 1% 1% 0.5% 0.5% OINTMENT Discontinued 2025-04-25 2025-04-25 255840
TEVA-PROFEN 600MG TABLET Discontinued 2025-05-28 2025-05-28 258499
TEVA-PROGESTERONE 100MG CAPSULE Reversed 2025-05-28 2025-06-20 258574
TEVA-QUETIAPINE 100MG TABLET Discontinued 2018-10-19 2018-10-19 64846
TEVA-QUETIAPINE 200MG TABLET Discontinued 2018-10-19 2018-10-19 65039
TEVA-QUETIAPINE 100MG TABLET Discontinued 2018-10-19 2018-10-19 65036
TEVA-QUETIAPINE 25MG TABLET Discontinued 2018-10-19 2018-10-19 64849
TEVA-QUETIAPINE 25MG TABLET Discontinued 2018-10-19 2018-10-19 65044
TEVA-QUETIAPINE 300MG TABLET Discontinued 2018-10-19 2018-10-19 65047
TEVA-QUININE 200MG CAPSULE Discontinued 2020-10-08 2020-10-09 125976
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
TEVA-RABEPRAZOLE EC 20MG TABLET (DELAYED-RELEASE) Discontinued 2020-07-10 2020-07-10 120015
TEVA-RABEPRAZOLE EC 10MG TABLET (DELAYED-RELEASE) Discontinued 2020-07-10 2020-07-10 120018
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136